Conversational AI organization Openstream.ai announced a new patent for automated digital twin technology that gives EVA, or enterprise virtual assistant, users the ability to utilize virtual assistants that are digital twins of human experts in their respective fields.
The digital twins share their human counterparts' knowledge and unique personas and engage in empathetic, hallucination-free...
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.
These include a project that will establish a patient dataset of inherited retinal diseases; a rapid multi-omic liquid biopsy blood test using whole genome sequencing; research using next-generation sequencing to develop new solutions to...
Assisted reproductive service provider Virtus Health is taking its customer relations management to the cloud, enhanced by AI.
It has chosen American company RingCentral to deliver an integrated communications and contact centre solution across its 62 fertility clinics, day hospitals, and diagnostics centres worldwide, mostly in Australia. Featuring RingCentral MVP and Contact Centre, the...
The healthcare sector witnessed a significant transformation in 2023, largely driven by the integration of artificial intelligence (AI) in patient diagnostics. This integration marks a revolutionary step in how medical professionals approach diagnosis, offering a blend of efficiency, accuracy and personalization previously unattainable.
The dawn of AI-driven diagnostics
Artificial intelligence in...
Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/.
As 2023 comes to a close, Jay Rughani, investment partner at Andreessen Horowitz, joined MobiHealthNews to discuss his takeaways from the year, noteworthy events, recommendations for regulators forming rules around AI in...
At the HIMSS AI in Healthcare Forum in San Diego on Dec. 14, a group of panelists outlined tactical pathways to artificial intelligence adoption and investment, including how to maximize impact and decisions around adopting existing tools or building new AI infrastructure.
Anne Snowdon, CEO of Scan Health and chief research officer at HIMSS, said that determining strategic priorities and setting...
The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes.
With an estimated valuation of $15.1 billion for the global market in 2022, AI in healthcare is an irreversible process that is already reshaping medicine and...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West.
Meanwhile, the AI cancer diagnostics solutions provider obtained its third 510(k) clearance from the United States Food and Drug Administration.
WHAT IT'S FOR
In a company disclosure,...
